What we do
The Venture
Chronic inflammation drives diverse diseases that collectively represent the leading causes of disability and mortality worldwide, such as cardiovascular disease, chronic kidney disease, neurodegenerative disorders, and autoimmune problems such as rheumatoid arthritis. While there are therapeutic approaches that can work well in these indications, many patients do not respond to treatment, others lose responsiveness, and some diseases still entirely lack adequate therapy, leaving great unmet medical need in an underserved space.
Our goal is to improve the lives of patients with serious and chronic inflammatory diseases by focusing on the development of medicines that more precisely affect key aspects of the disease - a new generation of targeted medicines - developed against targets uncovered through a global and intimate understanding of drivers of disease. We aim to do this through leveraging functional perturbation modeling, multi-omics, AI, and primary complex models for better contextual awareness of drug discovery.
We are working at the cusp of technology and biology - developing novel technology to answer critical questions in drug discovery and development, with a proven team of biotech and tech entrepreneurs and scientists.
We're seeking a passionate founder’s associate to help bring our new techbio solution to life. As a founder’s associate, you'll be instrumental in supporting the pre-seed build and seed preparation, validating strategy with pharma KOLs to scaling the organization. If you have an entrepreneurial spirit, a keen interest in AI, and a desire to make a meaningful impact in patients' lives, consider joining us.
PART OF AN ECOSYSTEM
The venture that you will be working for is part of the world’s first AI Venture Studio, Merantix. Already today, AI automates complex, multi-level processes that used to be dependent on human decision-making, resulting in automation and higher accuracy. Merantix aims to spearhead this development, building the category leaders of tomorrow. At Merantix Venture Studio, we build and scale machine-learning companies. Through our unique incubation platform, pre-seed financing and exceptional teams of visionary entrepreneurs and engineers, we transfer world-leading research into products that will change existing and create new industries. The growing platform constitutes a unique brand with a shared tech and operational infrastructure that attracts talent, resonates with industry partners, and leverages the proven network and product-building experience. Together with more than 60 AI teams, we collaborate on the AI Campus in the heart of Berlin. We are a big community of startups, scaleups, researchers, investors and enterprises that love to help and support each other with a shared vision of building disruptive technologies.